[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"stress-management\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:stress-management":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,42,73],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":4,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":37,"leadSponsor":39,"locationsCount":4},"100631819","breathing-and-decision-making-prolex-context-100631819",false,"NCT07505641","Breathing and Decision-Making (ProlEx-Context)","ProlEx-Context","Inclusion Criteria:\n\n* 18- to 40-year-old men and women\n* Consent to participate\n* Fluent in German\n* Right-handed\n* Physically and mentally healthy without regular medication\n* Body-mass index of 18-25 kg\u002Fm2\n* Alcohol consumption of less than 15 glasses a week (equivalent to one glass of wine\u002Fbeer, a glass of higher-percentage alcohol counts as two glasses of beer)\n* No illegal drug consumption in the week previous to the experiment\n* No smoking\n* No competitive athletes\n* Normal day-night rhythm (no shift work)\n* Normal vision without required vision correction (i.e., glasses, contact lenses; ability to clearly read texts at a distance of up to 50 cm without vision aids)\n\nExclusion Criteria:\n\n* Former or current illnesses of:\n* Brain or mind (including anxiety disorders, depression, eating disorders, personality disorders, alcohol, drugs or drug dependence, neurological disorders other than occasional headache, psychiatric or neurological abnormalities)\n* Heart or blood circulation\n* Lung Diseases\n* Other serious past or present medical conditions (for example, metabolic syndrome, diabetes)\n* Current medication and medication over a period of two weeks prior to the examination\n* Other serious health problems or present strong mental or physical stress\n* Current infection or excessive stress\n* Missing consent to receive information about incidental findings from the MRI\n* Tendency to claustrophobia, dizziness, or panic attacks\n* Wearing a non-removable pacemaker, defibrillator, hearing aid, drug pump, neurostimulator or implant with solenoid valve (e.g., artificial bowel outlet)\n* Metal parts or implants inside the body, for example, due to surgery or injury with a metallic foreign object (e.g., hip replacements, artificial joints, heart valves, vessel occlusions or dilatations, surgical clips, bone screws or plates, coil, shunts, catheters, electrodes, coils, radiation sources, shrapnel, projectiles, stents)\n* Having non-removable metal parts or metal-containing devices on or in the body\n* Having ferromagnetic metal parts or implants inside the body (e.g., hip replacements, artificial joints, heart valves, vessel occlusions or dilatations, surgical clips, bone screws or plates, coils, shunts, catheters, electrodes, coils, radiation sources, shrapnel, projectiles, stents)\n* Wearing magnetically fixed implants (e.g. amalgam fillings, glass eye)\n* Professionally or privately being involved in the processing of ferromagnetic metals\n* Large tattoos (whole limbs)\n* Pregnancy\n* Wearing an intra-uterine device\n* Having tinnitus\n* Extensive lung function (e.g. apnoe diver, singer, professional musician with lung-involving instruments)\n* Previous participation in the ProlEx-MRI study (the precursor to the current study)",true,"ALL","18 Years","40 Years",{"count":21,"type":22},50,"ESTIMATED","INTERVENTIONAL",[25],"NA","The ProlEx-Context study aims to investigate how a slow-paced breathing technique with prolonged exhalation affects decision-making in the context of acute social stress.",[28,29,30],"Breathing Techniques","Stress Management","Decision-Making","NOT_YET_RECRUITING","2026-03-26",{"date":34,"type":35},"2026-04-01","ACTUAL",{"date":34,"type":22},{"date":38,"type":22},"2027-04-01",{"name":40,"class":41},"German Institute of Human Nutrition","OTHER",{"id":43,"slug":44,"hasResults":11,"nctId":45,"briefTitle":46,"officialTitle":47,"acronym":4,"eligibilityCriteria":48,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":49,"targetDuration":4,"studyType":23,"phases":51,"briefSummary":52,"conditions":53,"keywords":58,"overallStatus":62,"whyStopped":4,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":66,"completionDateStruct":68,"leadSponsor":70,"locationsCount":72},"100518995","self-management-interventions-after-an-icd-shock-100518995","NCT06037785","Self-Management Interventions After an ICD Shock","Biobehavioral Intervention to Reduce PTSD After ICD Shock","Inclusion Criteria:\n\n1. ICD implant for primary or secondary prevention of sudden cardiac arrest (SCA),\n2. receipt of at least 1 ICD shock, appropriate or inappropriate, one week prior to enrollment;\n3. able to read, speak and write English;\n4. access to online resources and telephone for study duration.\n\nExclusion Criteria:\n\n1. current diagnosis of PTSD, schizophrenia or bipolar disorder;\n2. Short BLESSED score \\>6 indicating cognitive dysfunction \\[73\\];\n3. age \\\u003C18 years;\n4. AUDIT-C score ≥4 for alcohol use;\n5. regular non-medical use of illicit drugs",{"count":50,"type":22},60,[25],"This study, \"Biobehavioral Intervention to Reduce PTSD Symptoms After an ICD Shock,\" addresses a critical need in cardiology care by describing the feasibility and acceptability of a timely, highly promising, electronically-delivered intervention for patients who have recently received an ICD delivered shock. The study intervention and outcomes are designed to reduce anxiety, enhance return to activities of daily living (ADLs), and prevent the development of severe distress and post-traumatic stress disorder (PTSD), and ultimately promote quality of life. The study is a two-arm, embedded mixed methods, randomized trial (N=60, 30\u002Fgroup). The purpose is to determine feasibility and potential effects of a self-management intervention (SPSM) plus usual care (UC) compared to UC alone, delivered during the critical 1 month period after an ICD shock when distress is high. The intervention will be delivered over 1 month following an ICD shock; a 6-month follow-up will be used to assess the sustainability of intervention effects and determine if the incidence of PTSD is reduced. SPSM includes: 1) training in heart rate (HR) self-monitoring; and 2) individualized learning through 4 self-paced, web-based modules. The study interventions are delivered at a crucial time, closely after an ICD shock when stress is high, but PTSD has not yet developed. The specific aims are to: 1) examine the effects of the SPSM intervention plus UC vs. UC alone on the primary outcome of ICD shock anxiety at 1 and 6 months post-shock event, 2) describe the impact of SPSM plus UC compared to UC alone on the secondary outcomes of total daily physical activity, depression, PTSD symptoms, QOL, salivary cortisol levels, and self-efficacy and outcome expectations at 1 and 6 months post-shock event, and 3) assess feasibility, acceptability, and safety of the SPSM intervention, SDOH will be used to describe differential responses to the SPSM intervention. This study fills a significant gap in the care of patients with an ICD, through the systematic testing of a brief, novel and cost-effective intervention that provides the knowledge and skills to improve quality of life. Study findings will be used to design future larger RCTs to test intervention effectiveness for more diverse samples and settings.",[54,55,56,29,57],"Implantable Defibrillator User","Stress Reaction","Ptsd","Social Cognitive Theory",[59,60,61],"implantable cardioverter defibrillator","ptsd","stress management","RECRUITING","2025-09-22",{"date":65,"type":35},"2025-09-24",{"date":67,"type":35},"2024-10-01",{"date":69,"type":22},"2026-07-31",{"name":71,"class":41},"University of Washington",1,{"id":74,"slug":75,"hasResults":11,"nctId":76,"briefTitle":77,"officialTitle":78,"acronym":79,"eligibilityCriteria":80,"healthyVolunteers":11,"sex":81,"minAge":82,"maxAge":83,"enrollmentInfo":84,"targetDuration":4,"studyType":23,"phases":86,"briefSummary":87,"conditions":88,"keywords":93,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":96,"lastUpdatePostDateStruct":97,"startDateStruct":99,"completionDateStruct":101,"leadSponsor":103,"locationsCount":72},"100595625","effects-of-mindfulness-based-self-efficacy-development-program-on-postmenopausal-women-100595625","NCT07034885","Effects of Mindfulness-Based Self-Efficacy Development Program on Postmenopausal Women","Effects of Mindfulness-Based Self-Efficacy Development Program on Menopausal Symptoms and Quality of Life in Postmenopausal Women: A Randomized Controlled Trial","MOPKA","Inclusion Criteria:\n\nInclusion criteria:\n\n* Individuals who are in the +1a or +1b substage of early postmenopause according to the STRAW+10 system (at least 12 months and at most 24 months have passed since their last menstrual period)\n* Are proficient in reading and writing Turkish\n* Are in a spouse or partner\n* Have entered menopause naturally\n* Do not have a physical disability such as a severe musculoskeletal disorder, neurological disease, or mobility limitation that would prevent the use of mindfulness techniques (e.g., seated meditation, breathing exercises, gentle body awareness exercises)\n* Have not used MBSR techniques in the last six months\n* Own a smartphone or internet-enabled device.\n\nExclusion Criteria:\n\n* Those who completed the pretest data collection forms incompletely,\n* Those who had any psychological disorder or experienced a traumatic event in the last two to one years,\n* Those who received hormone replacement therapy during menopause,\n* Those who had any gynecological cancer","FEMALE","45 Years","57 Years",{"count":85,"type":22},70,[25],"The aim of this randomized controlled clinical trial is to evaluate the effects of a mindfulness-based self-efficacy development program on menopausal symptoms and quality of life in postmenopausal women. The main questions it aims to answer are:\n\nDoes the mindfulness-based program reduce the severity of menopausal symptoms?\n\nDoes the mindfulness-based program improve the quality of life of postmenopausal women?\n\nDoes the mindfulness-based program significantly increase participants' overall self-efficacy?\n\nThe researchers will compare whether there are differences between the mindfulness-based training program applied to the intervention group and the control group in terms of menopausal symptoms, quality of life, and self-efficacy scores.\n\nThe main tasks that will be asked of the participants are as follows:\n\nThose in the intervention group will participate in a face-to-face mindfulness-based self-efficacy development program, each session lasting at least 120 minutes, once a week for 8 weeks, with a maximum of 10 people per group.\n\nThe control group will not receive any intervention.\n\nParticipants in both groups will be evaluated with a personal information form and measurement tools such as the Menopause Symptoms Assessment Scale, the Menopause Specific Quality of Life Scale, and the General Self-efficacy Scale.",[89,90,91,29,92],"Postmenopausal Period","Menopausal Symptoms","Quality of Life","Self-Efficacy",[94,92,91,95],"Menopause","Mindfulness","2025-07-17",{"date":98,"type":35},"2025-07-22",{"date":100,"type":22},"2025-09-15",{"date":102,"type":22},"2026-02-28",{"name":104,"class":105},"Nurcan Gökgöz","OTHER_GOV"]